Exercise boosts Well-Being in leukemia patients on targeted therapy
NCT ID NCT06299540
First seen Oct 31, 2025 · Last updated May 21, 2026 · Updated 26 times
Summary
This study looks at whether a tailored physical activity plan can help people with chronic lymphocytic leukemia (CLL) feel better while taking the drug ibrutinib. About 180 participants will be followed for up to 12 months to measure changes in their quality of life, including physical, emotional, and social well-being. The goal is to see if adding exercise to standard care improves daily living for these patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut Universitaire du Cancer Toulouse Oncopole
RECRUITINGToulouse, 31059, France
Conditions
Explore the condition pages connected to this study.